Radiation national cancer institute u s. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Tumor Cells, Cultured

Organisms2

Mice, Nude Rats, Inbred F344

Diseases47

Neoplasms Radiation Injuries Breast Neoplasms Lung Neoplasms Prostatic Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Colorectal Neoplasms Neoplasm Recurrence, Local Colonic Neoplasms Neoplasm Metastasis Neoplasms, Second Primary Adenocarcinoma Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Carcinoma Disease Progression Neoplasm Invasiveness Uterine Cervical Neoplasms Carcinoma, Squamous Cell Skin Neoplasms Brain Neoplasms Urinary Bladder Neoplasms Head and Neck Neoplasms Melanoma Genetic Predisposition to Disease Kidney Neoplasms Carcinoma, Small Cell Rectal Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Neutropenia Genital Neoplasms, Female Neoplasms, Experimental Leukemia, Lymphocytic, Chronic, B-Cell Liver Neoplasms Lymphoma, Non-Hodgkin Vomiting Nausea Gastrointestinal Neoplasms Thyroid Neoplasms Neoplasms, Ductal, Lobular, and Medullary Bone Neoplasms Miosis Precursor Cell Lymphoblastic Leukemia-Lymphoma Sarcoma

Chemicals and Drugs35

Antineoplastic Agents Cisplatin Tumor Markers, Biological Paclitaxel Fluorouracil Organoplatinum Compounds Deoxycytidine Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Prostate-Specific Antigen Antineoplastic Agents, Alkylating Carcinogens Neoplasm Proteins Dacarbazine Vinblastine Cyclophosphamide Tamoxifen Taxoids Receptors, Estrogen Carboplatin Camptothecin Antibodies, Monoclonal Cancer Vaccines Tumor Suppressor Protein p53 DNA, Neoplasm Quinazolines Topotecan Antibodies, Monoclonal, Humanized Vincristine Antineoplastic Agents, Hormonal Doxorubicin Vidarabine Phosphate Radiation-Sensitizing Agents RNA, Messenger Chromium Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

SEER Program Radiation Dosage Drug Screening Assays, Antitumor Clinical Trials as Topic Treatment Outcome Dose-Response Relationship, Radiation Radiation Monitoring Antineoplastic Combined Chemotherapy Protocols Survival Rate Survival Analysis Incidence Combined Modality Therapy Early Detection of Cancer Registries Retrospective Studies Radiotherapy Neoplasm Staging Follow-Up Studies Prognosis Disease-Free Survival Risk Factors Drug Administration Schedule Radiotherapy Dosage Risk Assessment Research Design Clinical Trials, Phase III as Topic Multicenter Studies as Topic Prospective Studies Risk Chemotherapy, Adjuvant Cohort Studies Questionnaires Radiotherapy, Adjuvant Infusions, Intravenous Kaplan-Meier Estimate Reproducibility of Results Patient Selection Logistic Models Carcinogenicity Tests Odds Ratio Mass Screening Clinical Trials, Phase I as Topic Multivariate Analysis Mammography Clinical Trials, Phase II as Topic Maximum Tolerated Dose Dose Fractionation Mastectomy, Segmental Sensitivity and Specificity Radiation Injuries, Experimental Gene Expression Profiling Drug Evaluation, Preclinical Neoplasms, Experimental Data Collection Administration, Oral Prevalence Mastectomy Confidence Intervals Epidemiologic Studies Xenograft Model Antitumor Assays Radiometry Predictive Value of Tests Lymph Node Excision Mastectomy, Simple Feasibility Studies Population Surveillance Neoplasm Grading Endpoint Determination Probability Drug Evaluation Regression Analysis Cross-Sectional Studies Tomography, X-Ray Computed Proportional Hazards Models Pilot Projects Models, Statistical Program Evaluation Remission Induction Oligonucleotide Array Sequence Analysis Randomized Controlled Trials as Topic Mutagenicity Tests Case-Control Studies

Psychiatry and Psychology2

Smoking Cooperative Behavior

Phenomena and Processes26

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Time Factors Risk Dose-Response Relationship, Drug Drug Resistance, Neoplasm Odds Ratio Gene Expression Regulation, Neoplastic Cosmic Radiation Genetic Predisposition to Disease Maximum Tolerated Dose Sensitivity and Specificity Gamma Rays Mutation Diet Cell Survival Background Radiation Ultraviolet Rays Probability Apoptosis Genotype Algorithms Cell Cycle

Disciplines and Occupations6

Medical Oncology Radiation Oncology Biomedical Research Research Design Research Translational Medical Research

Anthropology, Education, Sociology and Social Phenomena12

National Cancer Institute (U.S.)National Institutes of Health (U.S.)National Institute for Occupational Safety and Health (U.S.)Government Programs Quality of Life National Heart, Lung, and Blood Institute (U.S.)Forecasting Age Distribution Community Networks Health Education United States Food and Drug Administration International Cooperation

Humanities1

Quality of Life

Information Science17

SEER Program Survival Rate Incidence Registries Databases, Factual Questionnaires Information Services Databases as Topic Community Networks Data Collection Prevalence Internet Online Systems Hotlines Terminology as Topic Algorithms Medical Informatics

Named Groups8

European Continental Ancestry Group Survivors Research Personnel African Americans Ethnic Groups Hispanic Americans African Continental Ancestry Group Infant, Newborn

Health Care86

National Cancer Institute (U.S.)National Institutes of Health (U.S.)Academies and Institutes SEER Program Radiation Dosage Radiation Injuries Cancer Care Facilities Clinical Trials as Topic Research Support as Topic Treatment Outcome Dose-Response Relationship, Radiation Radiation Monitoring Survival Rate Survival Analysis Incidence Registries Retrospective Studies Follow-Up Studies Radiation Protection Disease-Free Survival Age Factors Risk Factors National Institute for Occupational Safety and Health (U.S.)American Cancer Society Institute of Medicine (U.S.)Risk Assessment Pharmacy and Therapeutics Committee Tissue Banks Clinical Trials, Phase III as Topic Multicenter Studies as Topic Prospective Studies Risk Cohort Studies Questionnaires National Heart, Lung, and Blood Institute (U.S.)Kaplan-Meier Estimate Reproducibility of Results National Health Programs Patient Selection Logistic Models Sex Factors Odds Ratio Congresses as Topic Mass Screening Clinical Trials, Phase I as Topic Multivariate Analysis Clinical Trials, Phase II as Topic Cosmic Radiation Financing, Government Professional Staff Committees Sensitivity and Specificity Radiation Injuries, Experimental Age Distribution Community Networks Ethnic Groups Data Collection Prevalence Confidence Intervals Confounding Factors (Epidemiology)Epidemiologic Studies Practice Guidelines as Topic Occupational Exposure Health Planning Guidelines Health Education International Agencies Predictive Value of Tests Feasibility Studies Population Surveillance United States Food and Drug Administration Ultraviolet Rays Health Services Accessibility Cost-Benefit Analysis Probability Regression Analysis Cross-Sectional Studies Proportional Hazards Models Healthcare Disparities Pilot Projects Guidelines as Topic Program Development Models, Statistical Program Evaluation Randomized Controlled Trials as Topic Environmental Exposure Community Health Services Case-Control Studies

Geographicals6

United States Canada Egypt Delaware Republic of Korea Great Britain

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

National Cancer Institute (U.S.)National Institutes of Health (U.S.)United States Neoplasms Academies and Institutes SEER Program Radiation Dosage Radiation, Ionizing Radiation Injuries Antineoplastic Agents Breast Neoplasms Cancer Care Facilities Drug Screening Assays, Antitumor Clinical Trials as Topic Research Support as Topic Medical Oncology Treatment Outcome Dose-Response Relationship, Radiation Radiation Monitoring Antineoplastic Combined Chemotherapy Protocols Survival Rate Survival Analysis Incidence Radiation Tolerance Combined Modality Therapy Early Detection of Cancer Lung Neoplasms Registries Retrospective Studies Radiation Radiotherapy Neoplasm Staging Prostatic Neoplasms Radiation Oncology Biomedical Research Follow-Up Studies Prognosis Radiation Protection Disease-Free Survival Ovarian Neoplasms Canada Age Factors Risk Factors National Institute for Occupational Safety and Health (U.S.)American Cancer Society Drug Administration Schedule Time Factors Neoplasms, Radiation-Induced Institute of Medicine (U.S.)Databases, Factual Colorectal Neoplasms Radiotherapy Dosage Neoplasm Recurrence, Local Risk Assessment Government Programs Cisplatin Pharmacy and Therapeutics Committee Colonic Neoplasms Tissue Banks Research Design Clinical Trials, Phase III as Topic Multicenter Studies as Topic Prospective Studies Neoplasm Metastasis Neoplasms, Second Primary Adenocarcinoma Tumor Markers, Biological Cell Line, Tumor Risk Chemotherapy, Adjuvant Research European Continental Ancestry Group Stomach Neoplasms Paclitaxel Cohort Studies Dose-Response Relationship, Drug Carcinoma, Non-Small-Cell Lung Fluorouracil Questionnaires Quality of Life National Heart, Lung, and Blood Institute (U.S.)Drug Resistance, Neoplasm Radiotherapy, Adjuvant Pancreatic Neoplasms Infusions, Intravenous Kaplan-Meier Estimate Reproducibility of Results Carcinoma Information Services Disease Progression Neoplasm Invasiveness Uterine Cervical Neoplasms Databases as Topic National Health Programs Patient Selection Organoplatinum Compounds Carcinoma, Squamous Cell Deoxycytidine Survivors Skin Neoplasms

No FAQ available that match "radiation national cancer institute u s"